Sign in

CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
  1. S-3 Offering Registration Statement
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Executive or director change
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Other events
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Shares withheld for taxes 10% owner gave up 68,534 shares (to pay taxes)
  10. 4 Shares withheld for taxes Director gave up 54,074 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure

Page 18 of 22 · 422 filings